Furthermore, hepcidin levels, critical in iron regulation, were significantly higher in the MetS group (24.2 ± 1.93 μIU/mL) than in the non-MetS group (17.2 ± 2.25 μIU/mL, p = 0.03). The gene discussed is HAMP; the disease is metabolic syndrome.